AJR74: Joint Resolution Text

LRB-2422/1

JKS:klm

2023 - 2024 LEGISLATURE

2023 Assembly JOINT RESOLUTION 74

September 19, 2023 - Introduced by Representatives Subeck, Rozar, C. Anderson, J. Anderson, Andraca, Bare, Binsfeld, Cabrera, Clancy, Considine, Dittrich, Drake, Emerson, Haywood, Jacobson, Joers, S. Johnson, Madison, Magnafici, Melotik, Moore Omokunde, Murphy, Mursau, O'Connor, Ohnstad, Ortiz-Velez, Palmeri, Ratcliff, Shankland, Sinicki, Snodgrass, Stubbs, Vining and Kitchens, cosponsored by Senators Roys, Ballweg, Cabral-Guevara, Carpenter, Hesselbein, L. Johnson, Larson, Pfaff, Spreitzer, Taylor and Wirch. Referred to Committee on Rules.

AJR74,1,2 Relating to: designating September 2023 and September 2024 as Ovarian Cancer Awareness Month.

AJR74,1,4 Whereas, ovarian cancer is the deadliest of all gynecologic cancers and is most common in postmenopausal women; and

AJR74,1,7 Whereas, ovarian cancer ranks 17th in rates of new cancer cases among women in the United States, but ranks sixth among cancer deaths for women, and is the leading cause of death from cancer of the female reproductive system; and

AJR74,1,9 Whereas, ovarian cancer accounts for 2.1 percent of all new cancer cases for women, but 4.6 percent of all cancer deaths among women; and

AJR74,1,12 Whereas, every woman is at risk for ovarian cancer regardless of age, heritage, or medical history, and women with a family history of ovarian cancer and other genetic factors are at an even higher risk; and

AJR74,1,14 Whereas, approximately 230,000 women in the United States are living with ovarian cancer; and

AJR74,2,2 Whereas, the incidence of ovarian cancer in Wisconsin is slightly higher than the national average; and

AJR74,2,4 Whereas, only half of women diagnosed with ovarian cancer survive beyond five years; and

AJR74,2,7 Whereas, ovarian cancer may not cause early symptoms, and therefore its diagnosis often does not occur until the disease has reached an advanced stage, at which point the cancer may spread to other parts of the body; and

AJR74,2,10 Whereas, the five-year survival rate for Stage 1 ovarian cancer is more than 90 percent, but the five year-survival rate for late-stage ovarian cancer is below 30 percent, and only 17 percent of ovarian cancers are diagnosed at Stage 1; and

AJR74,2,12 Whereas, while a mammogram can detect breast cancer and a pap smear can detect cervical cancer, there is no reliable early detection test for ovarian cancer; and

AJR74,2,15 Whereas, additional ovarian cancer research and clinical trials are urgently needed to develop prevention strategies, early detection tools, and better therapies, in hopes of eventually finding a cure; and

AJR74,2,18 Whereas, awareness and education are crucial, and women's lives will be saved through public awareness about ovarian cancer and its risk factors, signs, and symptoms; now, therefore, be it

AJR74,2,21 Resolved by the assembly, the senate concurring, That the legislature proclaims September 2023 and September 2024 to be Ovarian Cancer Awareness Month in Wisconsin.

AJR74,2,22 (End)